$213 | SAVE $37 | Single User
$425 | SAVE $75 | Site License
$638 | SAVE $112 | Enterprise License

Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Report Updated: 10-03-2017]

Published by Global Data: 10 Mar 2017 | 48592 | In Stock
Related Topics: Healthcare

Introduction

Summary

Astellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a pharmaceutical company that provides drug products. The company offers pharmaceutical drugs in areas which include oncology, transplantation, urology, anti-infective, pain management and dermatology. It also provides discovery and development of new medicines and produce wide range of established products. The company has its presence in Iceland, Ireland, South Africa, Portugal, Spain, Norway, Denmark, Belgium, the Netherlands, Germany, Switzerland, Hungary, Serbia, Italy, Turkey, France, Romania, Ukraine, Russia, the UAE and the UK, among others. Astellas Pharma is headquartered in Chertsey, Surrey, the UK.

Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-03-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

    Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deal Details 10

    Asset Purchase 10

    MediGene Completes Sale Of European Rights For Eligard To Astellas 10

    Licensing Agreements 11

    Optimer Pharma Enters Into Licensing Agreement With Astellas Pharma Europe For Fidaxomicin 11

    Astellas Pharma Europe Expands Its Licensing Agreement With TOLMAR For Eligard 12

    Asset Transactions 13

    Grunenthal to Acquire Qutenza from Astellas Pharma Europe 13

    Astellas Pharma Europe Ltd - Key Competitors 15

    Key Employees 16

    Locations And Subsidiaries 17

    Head Office 17

    Other Locations & Subsidiaries 17

    Appendix 18

    Methodology 18

    About GlobalData 18

    Contact Us 18

    Disclaimer 18

List Of Tables
in Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-03-2017]

List of Tables

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Astellas Pharma Europe Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

MediGene Completes Sale Of European Rights For Eligard To Astellas 10

Optimer Pharma Enters Into Licensing Agreement With Astellas Pharma Europe For Fidaxomicin 11

Astellas Pharma Europe Expands Its Licensing Agreement With TOLMAR For Eligard 12

Grunenthal to Acquire Qutenza from Astellas Pharma Europe 13

Astellas Pharma Europe Ltd, Key Competitors 15

Astellas Pharma Europe Ltd, Key Employees 16

Astellas Pharma Europe Ltd, Subsidiaries 17

List Of Figures, Charts and Diagrams
in Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-03-2017]

List of Figures

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

48592 | GDPH103793D

Number of Pages

18

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Astellas Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc. is a pharm...
27 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile
SummaryAstellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which ...
14 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Inc. (4503) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which ...
12 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review
Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth ...
22 Mar 2016 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc. is a pharm...
09 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma US, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma US, Inc. (Astellas Pharma), a subsidiary of Astellas Pharma Inc. is a pharmac...
09 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Inc. (4503) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which ...
03 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile
SummaryAstellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which ...
24 Feb 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Physician Views: Can Astellas, Medivation's Xtandi meet expectations in pre-chemotherapy prostate cancer?
Scope Having secured approval for the treatment of pre-chemotherapy prostate cancer patients earlier...
25 Sep 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...